Molecular Insights into Leech-Derived Bioactive Compounds: Biochemical Mechanisms and Therapeutic Potential
Raghavi S, Deva Darshini B, Saravanan KM, Anbarasu K (2026) · International Journal of Molecular Sciences · n=0
Study Profile
- Design
- comprehensive narrative review of leech-derived bioactive compounds with focus on biochemical mechanisms, clinical applications, and translational biotechnology challenges (Saveetha Institute of Medical and Technical Sciences and AMET University, India)
- Sample size (n)
- 0
- Intervention
- Synthesis of proteomic and transcriptomic data identifying more than 100 bioactive leech salivary molecules (hirudin, calin, eglins, bdellins, destabilase, decorsin and others) and review of their biochemical roles in coagulation, inflammation, antimicrobial defense, wound healing, and angiogenesis
- Comparator
- Not applicable - narrative review of biochemistry and clinical applications across multiple historical eras
- Primary endpoint
- Catalog of leech-derived bioactive molecules and their molecular targets; review of clinical applications across reconstructive surgery, wound healing, cardiovascular health, musculoskeletal conditions, and emerging drug-delivery systems
- Primary result
- More than 100 bioactive molecules documented in leech saliva including hirudin, calin, eglins, bdellins, destabilase, and decorsin; mechanisms span anticoagulation, anti-inflammatory action, antimicrobial activity, antioxidant effects, and regenerative signaling; clinical applications detailed in reconstructive/microsurgical practice (venous congestion, graft success); emerging applications in wound healing, cardiovascular health, musculoskeletal conditions, regenerative medicine, drug-delivery systems (recombinant proteins, nanocarriers); biotechnology advances (recombinant production, high-throughput omics, nanotechnology) address scalability and standardization challenges
- Follow-up duration
- not applicable (narrative review)
- PMID
- 41828340
Key Findings
- Comprehensive contemporary catalog of leech salivary bioactive molecules — more than 100 distinct compounds documented
- Integrates biochemistry, clinical applications, and biotechnology challenges within a single review framework
- Highlights emerging drug-delivery applications (recombinant proteins and nanocarriers) as next-generation leech-derived therapeutics
- Identifies biological variation, infection risk, bleeding risk, and regulatory purity/standardization as key translational challenges
- Adds Indian research perspective to the global leech-pharmacology synthesis literature
Limitations
- Narrative review without systematic methodology or quantitative synthesis
- No primary mechanism or clinical data generated
- Selection of cited compounds and applications reflects authors' research interests
- Translational biotechnology discussion may oversimplify regulatory pathway complexity for recombinant proteins
- Does not provide GRADE-style certainty assessments for individual indications
Clinical Implications
Raghavi 2026 provides a useful contemporary synthesis bridging classical leech salivary biochemistry and emerging drug-delivery biotechnology. For ASH editorial purposes, the review is helpful contextual background on compound-registry pages and supports the editorial position that whole-leech therapy effects cannot be reduced to any single bioactive molecule. The review explicitly acknowledges the regulatory standardization challenges that affect both whole-leech device clearance (K040187) and recombinant pharmaceutical development. For US clinicians, the trial does not change practice but does provide a current reference for understanding the breadth of the leech-derived therapeutic landscape.
Related Trials
Medicinal leech therapy in venous congestion of microsurgical flaps: a randomized comparison with heparin pinprick scarification
Merlino G, Carbone S, Servillo G, Marletta DA (2020)
Adjunctive medicinal leech therapy for venous congestion in free flaps: a German multicenter randomized trial
Lehnhardt M, Daigeler A, Behr B, Schmidt SV, Wallner C (2021)
Medicinal leeches and the microsurgeon: a four-year study, clinical series and risk benefit review
Whitaker IS, Josty IC, Hawkins S, Azzopardi E, Naderi N, Graf J, Damaris L, Lineaweaver WC, Kon M (2011)
Medicinal leeches for surgically uncorrectable venous congestion after free flap breast reconstruction
Pannucci CJ, Nelson JA, Chung CU, Fischer JP, Kanchwala SK, Kovach SJ, Serletti JM, Wu LC (2014)